Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation

被引:45
作者
Herrera, Alex F. [1 ]
Soriano, Gabriela [1 ]
Bellizzi, Andrew M. [2 ]
Hornick, Jason L. [2 ]
Ho, Vincent T. [4 ]
Ballen, Karen K. [5 ]
Baden, Lindsey R. [3 ]
Cutler, Corey S. [4 ]
Antin, Joseph H. [4 ]
Soiffer, Robert J. [4 ]
Marty, Francisco M. [3 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Bone Marrow Transplant Unit, Boston, MA 02114 USA
关键词
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; UNRELATED DONORS; CHRONIC GRAFT; HEMATOLOGIC MALIGNANCIES; MYCOPHENOLATE-MOFETIL; HEPATIC COMPLICATIONS; PERIPHERAL-BLOOD; ADULT PATIENTS; RECIPIENTS;
D O I
10.1056/NEJMoa1104959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diarrhea is a frequent complication of hematopoietic stem-cell transplantation (HSCT). Important causes of diarrhea after HSCT include acute graft-versus-host disease (GVHD), infections, and medications. After the transplantation and engraftment of hematopoietic stem cells from umbilical-cord blood, we observed a new syndrome of culture-negative, antibiotic-responsive diarrhea not attributable to any known cause. Methods We conducted a retrospective cohort study of all patients undergoing cord-blood HSCT at our center between March 2003 and March 2010. The cord colitis syndrome was defined as a persistent diarrheal illness in such patients that was not due to acute GVHD, viral or bacterial infection, or another identifiable cause. Clinical and histopathological features of patients meeting the case definition were further analyzed. Results Among 104 patients who underwent cord-blood HSCT at our center, the cord colitis syndrome developed in 11 (10.6%). The 1-year Kaplan-Meier cumulative probability of meeting the case definition for the syndrome was 0.16. The median time to onset after transplantation was 131 days (range, 88 to 314). All patients had a response to a 10-to-14-day course of empirical therapy with metronidazole, alone or in combination with a fluoroquinolone. Five of the 11 patients (45%) had recurrent diarrhea shortly after discontinuation of antibiotics, and all patients who had a relapse had a response to reinitiation of antibiotic therapy. On histologic examination, all patients with the cord colitis syndrome had chronic active colitis, with granulomatous inflammation present in 7 of 11 patients (64%). Conclusions The cord colitis syndrome is clinically and histopathologically distinct from acute GVHD and other causes of diarrhea in patients who have undergone cord-blood HSCT and is relatively common in this patient population. The syndrome should be considered in such patients who have diarrhea that is not attributable to other causes.
引用
收藏
页码:815 / 824
页数:10
相关论文
共 34 条
[1]  
Asplund S, 1998, MODERN PATHOL, V11, P513
[2]   Double unrelated reduced-intensity umbilical cord blood transplantation in adults [J].
Ballen, Karen K. ;
Spitzer, Thomas R. ;
Yeap, Beow Y. ;
McAfee, Steven ;
Dey, Bimalangshu R. ;
Attar, Eyal ;
Haspel, Richard ;
Kao, Grace ;
Liney, Deborah ;
Alyea, Edwin ;
Lee, Stephanie ;
Cutler, Corey ;
Ho, Vincent ;
Soiffer, Robert ;
Antin, Joseph H. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) :82-89
[3]   Graft-versus-host disease - Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients [J].
Baudard, M ;
Vincent, A ;
Moreau, P ;
Kergueris, MF ;
Harousseau, JL ;
Milpied, N .
BONE MARROW TRANSPLANTATION, 2002, 30 (05) :287-295
[4]   Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies [J].
Boeckh, M ;
Nichols, WG ;
Papanicolaou, G ;
Rubin, R ;
Wingard, JR ;
Zaia, Y .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (09) :543-558
[5]   Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults [J].
Bow, EJ ;
Loewen, R ;
Cheang, MS ;
Shore, TB ;
Rubinger, M ;
Schacter, B .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2254-2261
[6]   Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease [J].
Brunstein, Claudio G. ;
Barker, Juliet N. ;
Weisdorf, Daniel J. ;
DeFor, Todd E. ;
Miller, Jeffrey S. ;
Blazar, Bruce R. ;
McGlave, Philip B. ;
Wagner, John E. .
BLOOD, 2007, 110 (08) :3064-3070
[7]   Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis [J].
Cutler, C. ;
Stevenson, K. ;
Kim, H. T. ;
Brown, J. ;
McDonough, S. ;
Herrera, M. ;
Reynolds, C. ;
Liney, D. ;
Kao, G. ;
Ho, V. ;
Armand, P. ;
Koreth, J. ;
Alyea, E. ;
Dey, B. R. ;
Attar, E. ;
Spitzer, T. ;
Boussiotis, V. A. ;
Ritz, J. ;
Soiffer, R. ;
Antin, J. H. ;
Ballen, K. .
BONE MARROW TRANSPLANTATION, 2011, 46 (05) :659-667
[8]  
Davila ML, 2006, CURR OPIN GASTROEN, V22, P44
[9]   Malignancies after hematopoietic stem cell transplantation:: Many questions, some answers [J].
Deeg, HJ ;
Socié, G .
BLOOD, 1998, 91 (06) :1833-1844
[10]   Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes [J].
Dubberke, Erik R. ;
Reske, Kimberlay A. ;
Srivastava, Anand ;
Sadhu, Justin ;
Gatti, Robert ;
Young, Rebecca M. ;
Rakes, Lauren C. ;
Dieckgraefe, Brian ;
DiPersio, John ;
Fraser, Victoria J. .
CLINICAL TRANSPLANTATION, 2010, 24 (02) :192-198